| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2638898 | American Journal of Infection Control | 2011 | 4 Pages |
Abstract
In our recent experience with methicillin-resistant Staphylococcus aureus (MRSA) infections in 488 patients undergoing thoracic cardiovascular surgery, we found only 2 MRSA infections (one sternal and one graft site). Both patients received preoperative bacitracin and had a negative nares culture for MRSA before the initiation of bacitracin therapy. We conclude that preoperative MRSA screening cultures and bacitracin prophylaxis are neither clinically efficacious nor cost-effective in predicting or preventing MRSA in patients undergoing thoracic cardiovascular surgery.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Burke A. Cunha, Valsamma Thekkel, Paul Schoch, Linda Cosgrove,